0001127602-19-014668.txt : 20190403
0001127602-19-014668.hdr.sgml : 20190403
20190403165500
ACCESSION NUMBER: 0001127602-19-014668
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190329
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paulson John
CENTRAL INDEX KEY: 0001394923
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 19729746
MAIL ADDRESS:
STREET 1: 1133 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-03-29
0000885590
Bausch Health Companies Inc.
BHC
0001394923
Paulson John
1251 AVENUE OF THE AMERICAS
NEW YORK
NY
10020
1
Common Stock, No Par Value
2019-03-29
4
A
0
1113
24.70
A
41812
D
Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.
/s/ Kirsten O'Donnell, attorney-in-fact for John Paulson
2019-04-03